Home/ Supplements/ Probiotics/ Probiotic 24 billion CFU

Probiotic 24 billion CFU

product on market Capsule Biotech Nutritions Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Probiotic 24 billion CFU
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

L. acidophilus
L. plantarum
L. salivarius
S. thermophilus

Other Ingredients

Maltodextrin Fructooligosaccharides Vegetable Capsule
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: As a dietary supplement, take two (2) capsules with water one or more times per day, or as directed by a health care professional.

Warnings & Precautions

Caution: Do not exceed recommended dose.

Pregnant or nursing mothers, children under 18, and individuals with a known medical condition should consult a physician before using this or any dietary supplement.

Pregnant or nursing mothers, children under 18, and individuals with a known medical condition should consult a physician before using this or any dietary supplement.

Keep out of the reach of children.

Do not use if safety seal is damaged or missing.

Formulation Notes

Probiotic 24 billion CFU per serving

Additional Information

Made in USA GMP Good Manufacturing Practice Certified Facility

Please recycle Order online: www.BiotechNutrtions.com

Metadata

Product Details

UPC / SKU6 16983 00252 0
DSLD Entry Date2021-02-25
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID244059
Data Updated2026-04-11
Research

Research Evidence

691
Research Sources
52
Avg Quality
255
Clinical Trial
205
Meta Analysis
123
Rct
81
Systematic Review
18
Cochrane Review
2
Guideline
2
Regulatory Source
1
Other
1
Narrative Review
1
Openfda Safety
A Probiotics for preventing acute upper respiratory tract infections
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Probiotics for maintenance of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Probiotics for induction of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Probiotics for treating eczema
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Probiotics for treating acute infectious diarrhoea
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies
Systematic Review International journal of molecular sciences 2022 PubMed DOI
A Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Probiotics to prevent infantile colic
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
View all evidence for Probiotics →
Compare

Similar Products

View all Probiotics products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.